Peter John Sadler

This study identifies 16216 cisplatin-damaged genes in human lung cancer cells and shows cisplatin disrupts protein phosphorylation signalling by targeting 85% of protein kinase and 81% of phosphatase genes.

This study evaluates methods to address spectrophotometric interference in cytotoxicity assays of iron oxide nanoparticles on neural cells, finding that Resazurin with fluorometric readout is least affected by interference.